Immuno-comparative screening of adult-derived human liver stem/progenitor cells for immune-inflammatory-associated molecules
暂无分享,去创建一个
M. Najimi | M. Najar | C. Lombard | Makram Merimi | E. Sokal | L. Lagneaux | P. Lewalle | D. Bron | N. Meuleman | D. Agha
[1] T. Vanhaecke,et al. The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells , 2020, Journal of clinical medicine.
[2] E. Carosella,et al. Human Hepatocytes and Differentiated Adult-Derived Human Liver Stem/Progenitor Cells Display In Vitro Immunosuppressive Properties Mediated, at Least in Part, through the Nonclassical HLA Class I Molecule HLA-G , 2019, Journal of immunology research.
[3] P. Burra,et al. New Perspectives in Liver Transplantation: From Regeneration to Bioengineering , 2019, Bioengineering.
[4] K. Oestreich,et al. Ikaros Zinc Finger Transcription Factors: Regulators of Cytokine Signaling Pathways and CD4+ T Helper Cell Differentiation , 2019, Front. Immunol..
[5] D. Bartlett,et al. Inhibition of immune checkpoints PD-1, CTLA-4, and IDO1 coordinately induces immune-mediated liver injury in mice , 2019, PloS one.
[6] H. Afif,et al. Mesenchymal Stromal Cell-Based Therapy: New Perspectives and Challenges , 2019, Journal of clinical medicine.
[7] N. Henderson,et al. Immune cell regulation of liver regeneration and repair , 2018, Journal of Immunology and Regenerative Medicine.
[8] P. Hoff,et al. CTLA-4 Mediates Inhibitory Function of Mesenchymal Stem/Stromal Cells , 2018, International journal of molecular sciences.
[9] Jin-Young Yang,et al. Current Perspectives Regarding Stem Cell-Based Therapy for Liver Cirrhosis , 2018, Canadian journal of gastroenterology & hepatology.
[10] F. Rodeghiero,et al. High-throughput immunophenotypic characterization of bone marrow- and cord blood-derived mesenchymal stromal cells reveals common and differentially expressed markers: identification of angiotensin-converting enzyme (CD143) as a marker differentially expressed between adult and perinatal tissue sour , 2018, Stem Cell Research & Therapy.
[11] B. Christ,et al. Cellular and Molecular Mechanisms of Mesenchymal Stem Cell Actions , 2017, Stem cells international.
[12] Patrick Legembre,et al. CD95/Fas, Non-Apoptotic Signaling Pathways, and Kinases , 2017, Front. Immunol..
[13] M. Fayyad-kazan,et al. Immunoprofiling of Adult-Derived Human Liver Stem/Progenitor Cells: Impact of Hepatogenic Differentiation and Inflammation , 2017, Stem cells international.
[14] Hyunjoo Lee,et al. ICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells , 2017, Scientific Reports.
[15] A. Mohr,et al. Stem Cell Regulation by Death Ligands and Their Use in Cell Therapy , 2017 .
[16] T. Anagnostou,et al. The PD1:PD-L1/2 Pathway from Discovery to Clinical Implementation , 2016, Front. Immunol..
[17] G. Carpino,et al. Cell sources for regenerative medicine of the liver and endoderm organs: strategies and perspectives. , 2016, Stem cell investigation.
[18] M. Najimi,et al. Concise Review: Updated Advances and Current Challenges in Cell Therapy for Inborn Liver Metabolic Defects , 2016, Stem cells translational medicine.
[19] Caroline C. Jadlowiec,et al. Liver transplantation: Current status and challenges. , 2016, World journal of gastroenterology.
[20] B. Badran,et al. The immunomodulatory properties of human bone marrow-derived mesenchymal stromal cells are defined according to multiple immunobiological criteria , 2016, Inflammation Research.
[21] D. Lavillette,et al. The Expression of the Hepatocyte SLAMF3 (CD229) Receptor Enhances the Hepatitis C Virus Infection , 2014, PloS one.
[22] A. Caplan,et al. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine , 2013, Experimental & Molecular Medicine.
[23] F. Borrego. The CD300 molecules: an emerging family of regulators of the immune system. , 2013, Blood.
[24] M. Toungouz,et al. Characterization and functionality of the CD200-CD200R system during mesenchymal stromal cell interactions with T-lymphocytes. , 2012, Immunology letters.
[25] M. Fujimoto,et al. Inducible costimulator (ICOS) and ICOS ligand signaling has pivotal roles in skin wound healing via cytokine production. , 2011, The American journal of pathology.
[26] E. Sokal,et al. From hepatocytes to stem and progenitor cells for liver regenerative medicine: advances and clinical perspectives , 2011, Cell proliferation.
[27] J. Olynyk,et al. Tumor necrosis factor–like weak inducer of apoptosis is a mitogen for liver progenitor cells , 2010, Hepatology.
[28] B. Kwon. CD137-CD137 Ligand Interactions in Inflammation , 2009, Immune network.
[29] C. Riccardi,et al. GITR: a modulator of immune response and inflammation. , 2009, Advances in experimental medicine and biology.
[30] G. Behre,et al. Marked improvement of severe progressive systemic sclerosis after transplantation of mesenchymal stem cells from an allogeneic haploidentical-related donor mediated by ligation of CD137L , 2008, Leukemia.
[31] C. Sempoux,et al. Adult-Derived Human Liver Mesenchymal-Like Cells as a Potential Progenitor Reservoir of Hepatocytes? , 2007, Cell transplantation.
[32] M. Girgenrath,et al. TWEAK, via its receptor Fn14, is a novel regulator of mesenchymal progenitor cells and skeletal muscle regeneration , 2006, The EMBO journal.
[33] Yanan Li,et al. Death receptor‐3 mediates apoptosis in human osteoblasts under narrowly regulated conditions , 2006, Journal of cellular physiology.
[34] T. Roskams. Different types of liver progenitor cells and their niches. , 2006, Journal of hepatology.
[35] C. Hellerbrand,et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. , 2006, Journal of hepatology.
[36] D. Rothstein,et al. Impaired Recall of CD8 Memory T Cells in Immunologically Privileged Tissue1 , 2005, The Journal of Immunology.
[37] G. Freeman,et al. The B7–CD28 superfamily , 2002, Nature Reviews Immunology.
[38] G. Ramadori,et al. CD95/CD95L-mediated apoptosis of the hepatic stellate cell. A mechanism terminating uncontrolled hepatic stellate cell proliferation during hepatic tissue repair. , 1997, The American journal of pathology.